Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...

Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...

Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines has largely recovered ...

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Eli Lilly’s tirzepatide (Mounjaro), showed substantial potential as an anti-obesity agent in a Phase 3 study released last month. Mounjaro was approved by FDA on May 13 to control blood glucose ...

Pharmaceutical company Eli Lilly has filed four lawsuits against certain US medical spas, wellness centers, and compounding pharmacies in order to stop them from “the unlawful marketing and sale ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Lilly's , opens new tab Mounjaro launched in the UK in February, among the first markets outside the U.S. for the drugmaker and one of only a handful of countries where it competes directly with ...

Big Night by Eli Lilly and Company on YouTube. Mounjaro is used to treat patients with Type 2 diabetes. But the drug and similar medications have soared in popularity among people who aren't ...

Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines has largely recovered ...

Mounjaro, which is approved to treat Type 2 diabetes, is manufactured by and commercially available only through Eli Lilly. The company notes that the medications are available only in prefilled ...

Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as both medicines have largely recovered from ...